大洋生物(003017.SZ)：预计前三季度净利润同比增长44.35%—75.56%

Core Viewpoint - The company expects a significant increase in net profit for the first three quarters, driven by higher demand for its main products, potassium carbonate and veterinary raw materials, resulting in increased sales and prices [1] Financial Performance - The net profit attributable to shareholders is projected to be between 74 million and 90 million yuan, representing a year-on-year growth of 44.35% to 75.56% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 67 million and 82 million yuan, indicating a year-on-year increase of 39.04% to 70.17% [1] Market Influence - The increase in net profit is primarily attributed to market influences that have boosted the demand for the company's main products [1] - Both sales volume and prices have risen compared to the same period last year, contributing to an increase in gross profit margin [1]